Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04548752
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2020-09-12
Brief Title:
Testing the Addition of Pembrolizumab an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations
Sponsor:
Organization:
National Cancer Institute NCI